- Home
- DYN vs BHC Comparison
DYN vs BHC Comparison
Compare DYN & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DYN
- BHC
- Stock Information
- Founded
- DYN 1984
- BHC N/A
- Country
- DYN United States
- BHC Canada
- Employees
- DYN N/A
- BHC 20700
- Industry
- DYN Medicinal Chemicals and Botanical Products
- BHC Biotechnology: Pharmaceutical Preparations
- Sector
- DYN Health Care
- BHC Health Care
- Exchange
- DYN Nasdaq
- BHC Nasdaq
- Market Cap
- DYN 1.4B
- BHC 2.3B
- IPO Year
- DYN 2020
- BHC N/A
- Fundamental
- Price
- DYN $9.57
- BHC $6.41
- Analyst Decision
- DYN Strong Buy
- BHC Hold
- Analyst Count
- DYN 15
- BHC 5
- Target Price
- DYN $43.60
- BHC $7.20
- AVG Volume (30 Days)
- DYN 2.7M
- BHC 2.9M
- Earning Date
- DYN 08-11-2025
- BHC 07-31-2025
- Dividend Yield
- DYN N/A
- BHC N/A
- EPS Growth
- DYN N/A
- BHC N/A
- EPS
- DYN N/A
- BHC N/A
- Revenue
- DYN N/A
- BHC $9,731,000,000.00
- Revenue This Year
- DYN N/A
- BHC $3.71
- Revenue Next Year
- DYN N/A
- BHC $5.03
- P/E Ratio
- DYN N/A
- BHC N/A
- Revenue Growth
- DYN N/A
- BHC 8.53
- 52 Week Low
- DYN $6.36
- BHC $3.96
- 52 Week High
- DYN $47.45
- BHC $9.85
- Technical
- Relative Strength Index (RSI)
- DYN 32.17
- BHC 76.58
- Support Level
- DYN $10.00
- BHC $5.93
- Resistance Level
- DYN $10.74
- BHC $6.55
- Average True Range (ATR)
- DYN 0.88
- BHC 0.29
- MACD
- DYN -0.48
- BHC 0.11
- Stochastic Oscillator
- DYN 0.53
- BHC 98.60
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.